Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1469454019 | Hydrochlorothiazide + spironolactone 50mg/50mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1489185010 | Hydrochlorothiazide + spironolactone 50mg/50mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2579531019 | Co-spironozide 50mg/50mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490560019 | Product containing hydrochlorothiazide 50 mg and spironolactone 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3491922014 | Product containing hydrochlorothiazide 50 mg and spironolactone 50 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501793014 | Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3569607017 | Product containing only hydrochlorothiazide 50 mg and spironolactone 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569608010 | Product containing only hydrochlorothiazide 50 mg and spironolactone 50 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3679599018 | Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3679600015 | Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product containing spironolactone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide and spironolactone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product containing spironolactone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has basis of strength substance | Spironolactone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Spironolactone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | Product containing only hydrochlorothiazide and spironolactone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR